Imatinib mesylate therapy improves survival in patients with newly diagnosed Philadelphia chromosome-positive chronic myelogenous leukemia in the chronic phase: comparison with historic data (Q30885947)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Imatinib mesylate therapy improves survival in patients with newly diagnosed Philadelphia chromosome-positive chronic myelogenous leukemia in the chronic phase: comparison with historic data |
scientific article |
Statements
1 reference
Imatinib mesylate therapy improves survival in patients with newly diagnosed Philadelphia chromosome-positive chronic myelogenous leukemia in the chronic phase: comparison with historic data (English)
1 reference
Hagop M Kantarjian
1 reference
Alessandra Ferrajoli
1 reference
Stefan Faderl
1 reference
Srdan Verstovsek
1 reference
William Wierda
1 reference
Jorge Cortes
1 reference
Susan O'Brien
1 reference
Mary Beth Rios
1 reference
Guillermo Garcia-Manero
1 reference
Michael Keating
1 reference
Francis J Giles
1 reference
Jianqin Shan
1 reference
Moshe Talpaz
1 reference
1 December 2003
1 reference
Identifiers
1 reference